AngioDynamics loses EVP & CFO
Albany, N.Y.-based AngioDynamics’ executive vice president & CFO Joseph Gersuk retired from the company, effective January 31, 2013.
Gersuk will continue receiving current base salary and benefits from February 1, 2013, through September 30, 2013, according to the regulatory filing.
"Joe has tirelessly served as our CFO for the past 5 years," president & CEO Joseph DeVivo said in prepared remarks. "During his tenure, he has made many significant contributions to the company and most recently led the very successful integration of operations after our acquisition of Navilyst Medical."
Mark Frost, CFO senior VP of Albany Molecular Research will succeed Gersuk.
Frost will receive an annual base salary of $345,000 plus bonus up to 50% of his base salary, as well as an executive car allowance of $1,200 per month, and reimbursement of up to $1,500 for legal fees, according to regulatory documents.
Prior to AMRI, Frost was VP of finance at Smith & Nephew Endoscopy and CFO of Groupe Sovac Auto financial services at General Electric in Paris, France.
Read more
ProUroCare Medical has new board director
ProUroCare Medical (OTC:PUMD) named David Barrett as new board director.
Barrett is the former president & CEO at the Lahey Clinic in Burlington, Mass. He is currently a board director for Advantage Healthcare Solutions, CR Bard Commonfund, Sapphire Systems, and Juliet Marine.
Barrett is also a member of the life sciences advisory board of Safeguard Scientifics and is the former chairman of the Massachusetts Hospital Assn.
Read more
Medrobotics appoints 2 co-chairs for its medical advisory board
Raynham, Mass.- based Medrobotics named Dr. Eugene Myers and Dr. Marshall Strome as co-chairmen of the company’s worldwide medical advisory board.
Myers is professor and emeritus chair of the department of otolaryngology at the University of Pittsburgh School of medicine.
Strome is the immediate past professor and chairman of Cleveland Clinic’s head and neck institute. He performed the world’s first total human laryngeal transplant in 1998.
Read more
NxStage has new board director
Lawrence, Mass.-based NxStage Medical (NSDQ:NXTM) named Jean Mixer to its board of directors.
Mixer currently is CEO of Mixer Consulting, prior to which she was a partner at The Boston Consulting Group and was an officer at JP Morgan in New York.
Mixer is a board director of the Cambridge Trust Company, chair of the Compensation Committee, and a member of the Executive Committee, as well as chair of the HR board committee for the boys and girls clubs of Boston.
Read more
